Weill Cornell Medical College of Cornell University
Verified email at
Cited by
Cited by
European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update
M Rouprêt, M Babjuk, M Burger, O Capoun, D Cohen, EM Comperat, ...
European urology 79 (1), 62-79, 2021
Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy
G Salomon, J Köllerman, I Thederan, FKH Chun, L Budäus, T Schlomm, ...
European urology 54 (6), 1354-1362, 2008
Urothelial carcinoma of the bladder and the upper tract: disparate twins
DA Green, M Rink, E Xylinas, SF Matin, A Stenzl, M Roupret, ...
The Journal of urology 189 (4), 1214-1221, 2013
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer
H Zargar, PN Espiritu, AS Fairey, LS Mertens, CP Dinney, MC Mir, ...
European urology 67 (2), 241-249, 2015
Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature
LA Kluth, PC Black, BH Bochner, J Catto, SP Lerner, A Stenzl, R Sylvester, ...
European urology 68 (2), 238-253, 2015
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers
AM Kamat, PK Hegarty, JR Gee, PE Clark, RS Svatek, N Hegarty, ...
European urology 63 (1), 4-15, 2013
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
E Xylinas, M Kent, L Kluth, A Pycha, E Comploj, RS Svatek, Y Lotan, ...
British journal of cancer 109 (6), 1460-1466, 2013
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma
E Xylinas, M Rink, EK Cha, T Clozel, RK Lee, H Fajkovic, E Comploj, ...
European urology 65 (1), 210-217, 2014
Prognostic factors and risk groups in T1G3 non–muscle-invasive bladder cancer patients initially treated with bacillus Calmette-Guérin: results of a retrospective multicenter …
P Gontero, R Sylvester, F Pisano, S Joniau, K Vander Eeckt, V Serretta, ...
European urology 67 (1), 74-82, 2015
Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature
JJ Crivelli, E Xylinas, LA Kluth, M Rieken, M Rink, SF Shariat
European urology 65 (4), 742-754, 2014
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy
E Xylinas, M Rink, BD Robinson, Y Lotan, M Babjuk, A Brisuda, DA Green, ...
European Journal of Cancer 49 (8), 1889-1897, 2013
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy
A Ouzzane, P Colin, E Xylinas, G Pignot, MM Ariane, F Saint, N Hoarau, ...
European urology 60 (6), 1258-1265, 2011
Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance
G Ploussard, X Durand, E Xylinas, S Moutereau, C Radulescu, A Forgue, ...
European urology 59 (3), 422-429, 2011
A multinational, multi-institutional study comparing positive surgical margin rates among 22 393 open, laparoscopic, and robot-assisted radical prostatectomy patients
P Sooriakumaran, A Srivastava, SF Shariat, PD Stricker, T Ahlering, ...
European urology 66 (3), 450-456, 2014
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision …
M Rouprêt, V Hupertan, T Seisen, P Colin, E Xylinas, DR Yates, ...
The Journal of urology 189 (5), 1662-1669, 2013
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool
E Xylinas, L Kluth, N Passoni, QD Trinh, M Rieken, RK Lee, H Fajkovic, ...
European urology 65 (3), 650-658, 2014
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
BD Robinson, PJ Vlachostergios, B Bhinder, W Liu, K Li, TJ Moss, ...
Nature communications 10 (1), 2977, 2019
The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette …
P Gontero, R Sylvester, F Pisano, S Joniau, M Oderda, V Serretta, S Larré, ...
BJU international 118 (1), 44-52, 2016
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder
E Xylinas, BD Robinson, LA Kluth, BG Volkmer, R Hautmann, R Küfer, ...
European Journal of Surgical Oncology (EJSO) 40 (1), 121-127, 2014
The system can't perform the operation now. Try again later.
Articles 1–20